ABVC 8-K 2026-11-02

ABVC BIOPHARMA, INC. (ABVC) 8-K dated 2026-11-02 — accession 0001213900-26-114729.

ABVC BIOPHARMA, INC. (ABVC) is a biotechnology company listed on NASDAQ.

ABVC BIOPHARMA, INC. filed a 8-K on 2026-11-02. Accession 0001213900-26-114729.

This 8-K covers: Material agreement (Item 1.01), Agreement ended (Item 1.02), New debt obligation (Item 2.03), Unregistered share sale (Item 3.02), Shareholder vote results (Item 5.07), Reg FD disclosure (Item 7.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ABVC revenue for 2025-09-30 was $796.0K. Net income was -$1.2M. Revenue was up 104.5% from 2024-09-30 to 2025-09-30. ABVC currently screens at market cap $35.9M.

Not investment advice. The ABVC SEC hub lists recent forms. The stock page is the research view.